WASHINGTON, May 4, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at Digestive Disease Week (DDW) 2023, to be held in Chicago, IL and online from May 6-9, 2023.
The following will be presented:
May 7, 2023
Presentation Title: "THE ROLE OF TENASCIN-X IN IDIOPATHIC GASTROPARESIS: WGS ANALYSIS"Poster Number: Su1618Presenter: Dr. Sandra Paulina Smieszek, Head of GeneticsSession Type: Poster SessionSession Title: AGA Gastroparesis and Small Intestinal DysmotilitySession Time: 12:30 PM to 1:30 PM CDT
Presentation Title: "POOLED EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS STUDY VP-VLY-686-3301 AND VP-VLY-686-2301" Poster Number: Su1632Presenter: Dr. Jesse L. Carlin, Clinical Project LeadSession Type: Poster SessionSession Title: AGA Gastroparesis and Small Intestinal DysmotilitySession Time: 12:30 PM to 1:30 PM CDT
Presentation Title: "EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS IN STUDY VP-VLY-686-3301"Poster Number: Su1633Presenter: Dr. Jesse L. Carlin, Clinical Project LeadSession Type: Poster SessionSession Title: AGA Gastroparesis and Small Intestinal DysmotilitySession Time: 12:30 PM to 1:30 PM CDT
Presentation Title: "A BASELINE SEVERITY INFLATION ANALYSIS IN STUDY VP-VLY-686-3301 OF TRADIPITANT IN GASTROPARESIS"Poster Number: Su1634Presenter: Dr. Jesse L. Carlin, Clinical Project LeadSession Type: Poster SessionSession Title: AGA Gastroparesis and Small Intestinal DysmotilitySession Time: 12:30 PM to 1:30 PM CDT
For more information on DDW 2023, please refer to https://ddw.org/.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com
Elizabeth Van EveryHead of Corporate AffairsVanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com
View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-presentations-at-ddw-2023-301816683.html
SOURCE Vanda Pharmaceuticals Inc.